MyFinsight
Home
Blog
About
Contact
Download
Download image
(decrease) increase in
cash, cash...
-$6,762K
Net earnings
$2,538K
Depreciation and
amortization
$1,580K
Stock-based compensation
expense
$561K
Deferred income taxes
$437K
Other, net
$397K
Amortization of deferred
financing costs
$94K
Proceeds from short-term
borrowings
$1,979K
Proceeds from long-term
lease obligations
$226K
Net cash provided by
operating activities
-$4,265K
Net cash used in
investing activities
-$1,570K
Net cash used in
financing activities
-$853K
Effect of exchange rate
changes on cash, cash...
-$74K
Canceled cashflow
$5,607K
Canceled cashflow
$2,205K
Accounts payable and
other accrued...
-$4,908K
Capital expenditures
$1,570K
Repayments on short-term
borrowings
$1,356K
Receivables
$2,070K
something is missing
-$890K
Deferred revenue
-$642K
Inventories
$576K
Accrued payment in kind
('pik') interest
$490K
Income tax receivable
$246K
Provision for credit
losses
-$50K
Repayments on term loan
$750K
Employee taxes withheld
for stock-based...
$671K
Payments on
sale-leaseback financing...
$209K
Payments on long-term
lease obligations
$72K
Back
Back
Cash Flow
source: myfinsight.com
KEWAUNEE SCIENTIFIC CORP DE (KEQU)
KEWAUNEE SCIENTIFIC CORP DE (KEQU)